Empower Your Wellness Journey
Uber is Ready to Roll Out Self-Driving Cars for Passengers to Ride in
Advances in technology have led society to countless discoveries and new processes, such as increased efficiency in validation of the first parts in the production part-approval process, and even more incredible: self-driving cars, some of which will be run by Uber. A fleet of Fords and Volvos, capable of driving…
New Research Changes World View on Relationship Between Menopause and Heart Disease
New research has shown that women suffer from heart attacks and heart disease about a decade later than men, who lack estrogen in their system. Previous studies show that once estrogen levels drop after a woman goes through menopause, heart disease rates rapidly increased. However, in the latest research published…
Your Cell Phone May Be Out to Get You if You Are Not Careful
Your cell phone can keep you connected to friends around the world, bring you hours of enjoyment from different games and apps, and even let you catch that Pokemon you’ve been trying too hard to get at your local deli. But who knew your phone could be out to hurt…
Lower Alcohol Content in Beer and Wine Could Reduce Harmful Effects
New research suggests that lowering the alcohol content in beer and wine could reduce the harmful effects of drinking overall. Current estimates suggest that one in four deaths among people age 20 to 39 is connected to alcohol and that drinking accounts for 3.3 million deaths worldwide every year. By…
A Bracelet Fertility Tracker Just Hit the Market
“There’s an app for that” has become the common response to many problems that once plagued humanity. However, that wasn’t the case until quite recently for one of the most serious life roadblocks afflicting more than 6 million women: trouble getting pregnant. Luckily, a new product has hit the market: a…
Alzheimer’s Medication Shows Promise for Treatment of Disease in Phase III Trials
Alzheimer’s disease is the sixth leading cause of death in the U.S., but researchers have recently completed the first phase III clinical trial for a drug that targets a specific protein linked to the progression of the disease. The protein in question is called tau, and is responsible for forming…